Published in Cancer Weekly, June 12th, 1995
The therapy allowed women a median survival time of 37.5 months, compared to 24.4 months with the standard chemotherapy of cisplatin and cyclophosphamide. The findings come from clinical trials of nearly 400 women conducted by William McGuire, M.D., professor of medicine, Winship Cancer Center of Emory University.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.